Episodes

  • How to Maximize Valuation for Minimal Cost

    How to Maximize Valuation for Minimal Cost
    Aug 11 2025
    In this episode, “How to Maximize Valuation for Minimal Cost,” we explore a critical question: Are you focused on regulatory approval, or on maximizing value? Your answer could determine the path your clinical trial takes, and the outcome it delivers. Participants: Host: Dr. Ken Park, VP of R&D Strategy and Innovation Consulting for Fortrea Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals Terry Athreya, SVP and Global Head of Clinical Operations for Fortrea Alaric Jackson, Chief Technology and Data Officer at Fortrea
    Show More Show Less
    21 mins
  • Innovative Approaches to Enhance Productivity

    Innovative Approaches to Enhance Productivity
    Aug 11 2025
    This episode explores innovative approaches to enhance productivity within clinical trials, focusing on the use of technology and data-driven strategies. Participants: Host: Dr. Ken Park, VP of R&D Strategy and Innovation Consulting for Fortrea Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals Terry Athreya, SVP and Global Head of Clinical Operations for Fortrea Alaric Jackson, Chief Technology and Data Officer at Fortrea
    Show More Show Less
    21 mins
  • Collaboration Between Contract Research Organizations and Biotech Companies

    Collaboration Between Contract Research Organizations and Biotech Companies
    Aug 11 2025
    Wrap up our Driving Productivity in Biotech Clinical Trials podcast as we discuss collaboration between Contract Research Organizations and biotech companies, emphasizing the importance of communication and understanding in clinical trials. Participants: Host: Dr. Ken Park, VP of R&D Strategy and Innovation Consulting for Fortrea Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals Terry Athreya, SVP and Global Head of Clinical Operations for Fortrea Alaric Jackson, Chief Technology and Data Officer at Fortrea
    Show More Show Less
    11 mins